Loading...

Biden Says US to Hit 100 Million Vaccinations Goal on Friday

March 19, 2021by Zeke Miller, Associated Press
Biden Says US to Hit 100 Million Vaccinations Goal on Friday
President Joe Biden speaks about COVID-19 vaccinations, from the East Room of the White House, Thursday, March 18, 2021, in Washington. (AP Photo/Andrew Harnik)

WASHINGTON (AP) — With the U.S. closing in on President Joe Biden’s goal of injecting 100 million coronavirus vaccinations weeks ahead of his target date, the White House said the nation is now in position to help supply neighbors Canada and Mexico with millions of lifesaving shots.

The Biden administration on Thursday revealed the outlines of a plan to “loan” a limited number of vaccines to Canada and Mexico as the president announced the U.S. is on the cusp of meeting his 100-day injection goal “way ahead of schedule.”

” I’m proud to announce that tomorrow, 58 days into our administration, we will have met our goal,” Biden said. He promised to unveil a new vaccination target next week, as the U.S. is on pace to have enough of the three currently authorized vaccines to cover the entire adult population just 10 weeks from now.

Ahead of Biden’s remarks, the White House said it was finalizing plans to send a combined 4 million doses of the AstraZeneca COVID-19 vaccine to Mexico and Canada in its first export of shots. Press secretary Jen Psaki said the details of the “loan” were still being worked out, but 2.5 million doses would go to Mexico and 1.5 million would be sent to Canada.

“Our first priority remains vaccinating the U.S. population,” Psaki said. But she added that “ensuring our neighbors can contain the virus is a mission critical step, is mission critical to ending the pandemic.”

The AstraZeneca vaccine has not yet been authorized for use in the U.S. but has been by the World Health Organization. Tens of millions of doses have been stockpiled in the U.S., waiting for emergency use authorization, and that has sparked an international outcry that lifesaving vaccine is being withheld when it could be used elsewhere. The White House said just 7 million of the AstraZeneca doses are ready for shipment.

The initial run of doses manufactured in the U.S. are owned by the federal government under the terms of agreements reached with drugmakers, and the Biden administration has faced calls from allies across the globe to release the AstraZeneca shots for immediate use. Biden has also fielded direct requests from Canadian Prime Minister Justin Trudeau and Mexican President Andrés Manuel López Obrador to buy vaccines produced in the United States.

Global public health advocates say wealthy nations like the U.S. need to do far more to help stem the spread of the pandemic. The World Health Organization on Thursday issued a report that fewer than 7 million COVID-19 vaccine doses have been administered in Africa thus far. That’s the equivalent of what the U.S. administers in a matter of days.

Biden did move to have the U.S. contribute financially to the United Nations- and World Health Organization-backed COVAX alliance, which will share vaccine with more than 90 lower- and middle-income nations, but the U.S. has yet to commit to sharing any doses.

From his first days in office, Biden has set clear — and achievable — metrics for U.S. success, whether they be vaccinations or school reopenings, as part of an apparent strategy of underpromising, then overdelivering. Aides believe that exceeding his goals breeds trust in government after the Trump administration’s sometimes-fanciful rhetoric on the virus.

The 100 million-dose goal was first announced on Dec. 8, days before the U.S. had even one authorized vaccine for COVID-19, let alone the three that have now received emergency authorization. Still, it was generally seen within reach, if optimistic.

By the time Biden was inaugurated on Jan. 20, the U.S. had already administered 20 million shots at a rate of about 1 million per day, bringing complaints at the time that Biden’s goal was not ambitious enough. He quickly revised it upward to 150 million doses in his first 100 days.

Now the U.S. is injecting an average of about 2.2 million doses each day — and the pace is likely to dramatically rise later this month in conjunction with an expected surge in supply of the vaccines.

According to data from the Centers for Disease Control and Prevention, injections of 96 million doses have been reported to the agency since Biden’s inauguration, but those reports lag the actual date of administration. Vaccination trend lines pointed to Biden breaking the 100 million mark on Thursday, with the numbers likely to be confirmed by the CDC as soon as Friday.

The president has moved to speed up deliveries of vaccines from Pfizer, Moderna and Johnson & Johnson, as well as to expand the number of places to get shots and people who can administer them, with a focus on increasing the nation’s capacity to inject doses as supply constraints lift.

The risk in setting too rosy expectations is that an administration might become defined by its failure to meet them, such as in May 2020, when President Donald Trump said the nation had “prevailed” over the virus.

At the time, the country had seen about 80,000 deaths from the virus. This week, the U.S. death toll topped 538,000. Trump’s lax approach and lack of credibility also contributed to poor adherence to public safety rules among the American public.

In The News

Health

Voting

Health

January 14, 2022
by Dan McCue
White House Announces Plans to Distribute Home COVID Tests

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government,... Read More

WASHINGTON — Beginning Jan. 19, Americans will be able to order free at-home COVID-19 tests online from the federal government, a senior White House official announced Friday afternoon. In the early going of the new program, individuals will be limited to four free tests per residential... Read More

Mask Rules Get Tighter in Europe in Winter's COVID-19 Wave

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with... Read More

ROME (AP) — To mask or not to mask is a question Italy settled early in the COVID-19 outbreak with a vigorous “yes." Now the onetime epicenter of the pandemic in Europe hopes even stricter mask rules will help it beat the latest infection surge. Other... Read More

January 12, 2022
by Reece Nations
House Rules Committee Rejects G.I. Bill Education Benefits for Vaccine Refusal

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act... Read More

WASHINGTON — The House Rules Committee on Monday rejected an amendment to the Guard and Reserve G.I. Bill Parity Act that would guarantee Armed Services members discharged for refusing the COVID-19 vaccine are eligible for G.I. Bill education benefits. The Guard and Reserve G.I. Bill Parity... Read More

January 12, 2022
by Alexa Hornbeck
Reliability of Antigen Rapid Tests in Detecting Early Omicron Questioned

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite... Read More

WASHINGTON — Beginning Jan. 15, private health insurers will be required to cover the cost of home testing kits despite recent concerns from elected officials and researchers over the reliability and availability of rapid antigen testing. “I’ve heard from so many people who are waiting in... Read More

January 12, 2022
by Alexa Hornbeck
COVID Pills Show Promise for Combating Severe Infection

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health... Read More

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health show the pill may hold promise in saving lives. Shortly before Christmas Day, Paxlovid was authorized for at-home treatment of high-risk COVID-19 infections in patients over... Read More

January 12, 2022
by Alexa Hornbeck
Researchers Develop mRNA-based Lyme Disease Vaccine

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability... Read More

Yale researchers recently developed an mRNA-based Lyme disease vaccine capable of targeting antigens in tick saliva to prevent their ability to transmit pathogens.  According to the CDC, nearly half a million people in the U.S. are diagnosed with Lyme Disease every year. The ailment is most... Read More

News From The Well
Exit mobile version